Current commentaries about deep dyspareunia and the genito-urinary syndrome of menopause
نویسنده
چکیده
The authors carried out an evaluation of the genito-urinary syndrome of menopause, which is defined as a set of signs and symptoms associated with the reduction of estrogen and other sex steroids involving changes in labia maiora and minora, clitoris, vaginal vestibule, urethra and bladder, which create discomfort and are not better explained by another diagnosis. The syndrome may include, but not be limited to, genital symptoms of dryness, burning and irritation, sexual symptoms of lack of lubrication, discomfort or pain, and impaired functions, and may be associated with urinary symptoms of urgency, dysuria and recurrent urinary infections. Affected women may have some or all these signs and symptoms; however, specifically regarding deep dyspareunia, a discomfort caused by pain felt in the vaginal fundus during sexual relations, a better explanation is the relative short vagina syndrome. This syndrome is related to incompatibility of penis size with the size of the extended vagina or to an organic cause such as loss of vaginal elasticity due to atrophy caused by the lack of sex steroids, with consequent vaginal shortening and reduced capacity of vaginal distention. Accepting this explanation facilitates the approach to this symptom and permits gynecologists to treat affected women in an appropriate manner. The treatment of this type of discomfort requires changes in sexual practices during the climacteric and menopause, together with hormone replacement, as recommended by professionals who are aware of the two syndromes. Correspondence to: Ângelo C. S. Matthes, Av Costabile Romano, 2201. Ribeirão Preto, 14096-000, Brazil, Tel: 55 (16) 3603-7000, 55 (16) 981 45 85 65; E-mail: [email protected]
منابع مشابه
Dyspareunia in Puerto Rican middle-aged women.
OBJECTIVE Dyspareunia is a common sexual dysfunction. There is a lack of studies that address female sexual dysfunction in Puerto Rico. The present cross-sectional study characterized dyspareunia in a sample of Puerto Rican women aged 40 to 59 years and evaluated the relationship between reported dyspareunia with demographic, lifestyle, and health factors. METHODS Nine hundred twenty Puerto R...
متن کاملVaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause
Aim To evaluate the effects of the vaginal erbium laser (VEL) in the treatment of postmenopausal women suffering from genitourinary syndrome of menopause (GSM). Method GSM was assessed in postmenopausal women before and after VEL (one treatment every 30 days, for 3 months; n = 45); the results were compared with the effects of a standard treatment for GSM (1 g of vaginal gel containing 50 μg of...
متن کاملOverall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials
OBJECTIVE To evaluate the safety of daily oral ospemifene 60 mg, estrogen agonist/antagonist, used to treat moderate-to-severe dyspareunia due to postmenopausal vulvovaginal atrophy, which is part of genitourinary syndrome of menopause. METHODS Post hoc analysis of safety data (treatment-emergent adverse events [TEAEs]) pooled from six phase 2 and 3 randomized, double-blind, multicenter place...
متن کاملVaginal estrogen for genitourinary syndrome of menopause: a systematic review.
OBJECTIVE To comprehensively review and critically assess the literature on vaginal estrogen and its alternatives for women with genitourinary syndrome of menopause and to provide clinical practice guidelines. DATA SOURCES MEDLINE and Cochrane databases were searched from inception to April 2013. We included randomized controlled trials and prospective comparative studies. Interventions and c...
متن کاملMicroablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: An observational study.
OBJECTIVES This study aimed to assess the effect of the Microablative Fractional CO2 Laser (CO2-laser) therapy on vaginal pathophysiology and the symptoms of the Genitourinary Syndrome of Menopause (GSM). METHODS Postmenopausal women with moderate to severe symptoms of GSM underwent three sessions of CO2-laser therapy at monthly intervals. Participants were evaluated at baseline and 4 weeks a...
متن کامل